Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02222909 · ClinicalTrials.gov registry record · NA
Reverse Innovation and Patient Engagement to Improve Quality of Care and Patient Outcomes
A NA study, sponsored by Johns Hopkins Bloomberg School of Public Health.
- Completed
- Registry status
- NA
- Development phase
- 6,767
- Enrollment target
NCT02222909: Completed NA study, sponsored by Johns Hopkins Bloomberg School of Public Health.
NCT02222909 is a NA study that has completed, run by Johns Hopkins Bloomberg School of Public Health. The registered enrollment target is 6,767 participants, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (382% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02222909, a NA study, has completed, sponsored by Johns Hopkins Bloomberg School of Public Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 6,767 participants
- Enrollment target
Study Summary
Project CONNECT ("Community-based Organizations Neighborhood Network: Enhancing Capacity Together") is a randomized controlled trial that involves 22 community-based organizations (CBOs) located in Baltimore, MD. Half of these organizations were randomly assigned to the intervention group using a constrained cluster randomization process. The remaining 11 are a part of the control intervention group. The intervention is a co-developed set of IT tools hypothesized to improve the connections among intervention CBOs, Johns Hopkins health care facilities and CBO clients.
Primary Outcome
The change in the average number of monthly emergency department visits and days spent in the hospital from the pre- intervention to the post-intervention period for J-CHiP patients assigned to each of the CBOs, adjusted for baseline prognostic variables.
Interventions
- OTHER Co-developed IT intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6,767 participants |
| Start Date | 2014-04 |
| Est. Completion | 2015-12 |
| Phase | NA |
What the finished NCT02222909 record still lists
NCT02222909 is an interventional study that assigns participants to a tested intervention. Its 6,767 participants enrollment target places it among the larger protocols in the corpus, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (382% higher).
The record links to 0 conditions, and to 1 intervention - of which Co-developed IT intervention is the first listed.
NCT02222909 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02222909 about?
NCT02222909 is a clinical study titled "Reverse Innovation and Patient Engagement to Improve Quality of Care and Patient Outcomes". Project CONNECT ("Community-based Organizations Neighborhood Network: Enhancing Capacity Together") is a randomized controlled trial that involves 22 community-based organizations (CBOs) located in Baltimore, MD. Half of these organizations were randomly assigned to the intervention group using a co...
What is the current status of trial NCT02222909?
This trial is currently completed. It is a NA study. The enrollment target is 6,767 participants. The study started on 2014-04. Estimated completion is 2015-12.
What interventions are being tested in trial NCT02222909?
The interventions under investigation include: Co-developed IT intervention (OTHER).
Who is sponsoring clinical trial NCT02222909?
This trial is sponsored by Johns Hopkins Bloomberg School of Public Health, which has 187 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02222909's enrollment target sits among peer trials
6,767 21st of 2000 higher than 1,980 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03887715 · 6,800 participants · NA
A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy® System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression
- NCT06234384 · 6,833 participants
Foundation for Sarcoidosis Research Advanced Cures Registry (FSR-SARC Registry)
- NCT05121324 · 6,700 participants · Phase 3
Pediatric Dose Optimization for Seizures in Emergency Medical Services
- NCT06272045 · 6,618 participants · NA
Early Intervention to Promote Cardiovascular Health of Mothers and Children
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia